External broker reports(aggregated public sources), ICICI Securities Ltd

ICICI Securities Limited

External broker reports(aggregated public sources)

ICICI Securities Ltd

ICICI Securities Limited provides investment services. The Company provides corporate and investment banking, securities, wealth management, retail brokerage, initial public offerings, and advisory services. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Incorporated in 1947, PI Industries focuses on complex chemistry solutions in agri and pharma sciences.</li><li>The company maintains a strong research presence through its R&amp;D facility in Udaipur, where it has a dedicated team of over 300 scientists</li><li>We retain BUY on the back of better growth outlook of CSM business. </li></ul><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

Incorporated in 1947, PI Industries focuses on complex chemistry solutions in agri and pharma sciences.The company maintains a strong research presence through its R&amp;D facility in Udaipur, where it has a dedicated team of over 300 scientistsWe retain BUY on the back of better growth outlook of CSM business. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

PI Industries: Strong Order Book to Maintain CSM Momentum

External broker reports(aggregated public sources), Motilal Oswal Financial Services Limited

Motilal Oswal

<p>CSM segment going from strength to strength! PI's FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the next level in the global arena, with more substantive participation in the Life Sciences domain. Here are the key insights:...</p><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

CSM segment going from strength to strength! PI's FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the next level in the global arena, with more substantive participation in the Life Sciences domain. Here are the key insights:...Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

CSM segment going from strength to strength!

External broker reports(aggregated public sources), Axis Direct

Axis Direct

<p>We value PIIND at 36x (PE its FY24E EPS) given the strong performance on the export and domestic front and wait for more clarity on ramping up of newly acquired business that could be value accretive for shareholders.</p><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

We value PIIND at 36x (PE its FY24E EPS) given the strong performance on the export and domestic front and wait for more clarity on ramping up of newly acquired business that could be value accretive for shareholders.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

PI Industries: Growth Remains Intact with Foray into Pharma Segment

<p>Gross margins improved 180 bps YoY to ~43.8% while EBITDA margin contracted 80 bps YoY to 20.8%, due to higher employee (up 20% YoY) and other operating cost (up 32% YoY)...</p><div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

Gross margins improved 180 bps YoY to ~43.8% while EBITDA margin contracted 80 bps YoY to 20.8%, due to higher employee (up 20% YoY) and other operating cost (up 32% YoY)...Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

PI Industries: Next Growth Phase to Emanate from Pharma

India

PI Industries Limited manufactures agricultural and fine chemicals, and polymers. The Company produces fine chemicals; crop protection, plant nutrients, and seeds; and engineering plastics for use in the automobile, electrical, and home appliances industries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Pi Industries (PI IN)

PI Industries: Strong Order Book to Maintain CSM Momentum

Incorporated in 1947, PI Industries focuses on complex chemistry solutions in agri and pharma sciences. The company maintains a strong research...

ICICI Securities Limited

CSM segment going from strength to strength!

CSM segment going from strength to strength! PI's FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the...

Motilal Oswal

CSM segment going from strength to strength!

CSM segment going from strength to strength! PI's FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the...

Motilal Oswal

PI Industries: Growth Remains Intact with Foray into Pharma Segment

We value PIIND at 36x (PE its FY24E EPS) given the strong performance on the export and domestic front and wait for more clarity on ramping up of...

Axis Direct

PI Industries: Next Growth Phase to Emanate from Pharma

Gross margins improved 180 bps YoY to ~43.8% while EBITDA margin contracted 80 bps YoY to 20.8%, due to higher employee (up 20% YoY) and other...

ICICI Securities Limited

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)